Cephalexin is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by H.j. Harkins Company, Inc.. The primary component is Cephalexin.
| Product ID | 52959-031_749fe83a-d77e-46c1-8f31-6f318af9a2da | 
| NDC | 52959-031 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | Cephalexin | 
| Generic Name | Cephalexin | 
| Dosage Form | Capsule | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2006-02-01 | 
| Marketing Category | ANDA / ANDA | 
| Application Number | ANDA065215 | 
| Labeler Name | H.J. Harkins Company, Inc. | 
| Substance Name | CEPHALEXIN | 
| Active Ingredient Strength | 500 mg/1 | 
| Pharm Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [CS] | 
| NDC Exclude Flag | E | 
| Listing Certified Through | 2017-12-31 | 
| Marketing Start Date | 2006-02-01 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | ANDA | 
| Application Number | ANDA065215 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2006-02-01 | 
| Inactivation Date | 2019-11-13 | 
| Marketing Category | ANDA | 
| Application Number | ANDA065215 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2006-02-01 | 
| Inactivation Date | 2019-11-13 | 
| Marketing Category | ANDA | 
| Application Number | ANDA065215 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2006-02-01 | 
| Inactivation Date | 2019-11-13 | 
| Marketing Category | ANDA | 
| Application Number | ANDA065215 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2006-02-01 | 
| Inactivation Date | 2019-11-13 | 
| Marketing Category | ANDA | 
| Application Number | ANDA065215 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2006-02-01 | 
| Inactivation Date | 2019-11-13 | 
| Marketing Category | ANDA | 
| Application Number | ANDA065215 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2006-02-01 | 
| Inactivation Date | 2019-11-13 | 
| Marketing Category | ANDA | 
| Application Number | ANDA065215 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2006-02-01 | 
| Inactivation Date | 2019-11-13 | 
| Marketing Category | ANDA | 
| Application Number | ANDA065215 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2006-02-01 | 
| Inactivation Date | 2019-11-13 | 
| Marketing Category | ANDA | 
| Application Number | ANDA065215 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2006-02-01 | 
| Inactivation Date | 2019-11-13 | 
| Marketing Category | ANDA | 
| Application Number | ANDA065215 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2006-02-01 | 
| Inactivation Date | 2019-11-13 | 
| Marketing Category | ANDA | 
| Application Number | ANDA065215 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2006-02-01 | 
| Inactivation Date | 2019-11-13 | 
| Marketing Category | ANDA | 
| Application Number | ANDA065215 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2006-02-01 | 
| Inactivation Date | 2019-11-13 | 
| Marketing Category | ANDA | 
| Application Number | ANDA065215 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2006-02-01 | 
| Inactivation Date | 2019-11-13 | 
| Marketing Category | ANDA | 
| Application Number | ANDA065215 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2006-02-01 | 
| Inactivation Date | 2019-11-13 | 
| Marketing Category | ANDA | 
| Application Number | ANDA065215 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2006-02-01 | 
| Inactivation Date | 2019-11-13 | 
| Marketing Category | ANDA | 
| Application Number | ANDA065215 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2006-02-01 | 
| Inactivation Date | 2019-11-13 | 
| Marketing Category | ANDA | 
| Application Number | ANDA065215 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2006-02-01 | 
| Inactivation Date | 2019-11-13 | 
| Ingredient | Strength | 
|---|---|
| CEPHALEXIN | 500 mg/1 | 
| SPL SET ID: | effe46a4-c383-4171-8ab4-2af9de316f08 | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 0093-2238 | Cephalexin | Cephalexin | 
| 0093-2240 | Cephalexin | Cephalexin | 
| 0093-3145 | Cephalexin | Cephalexin | 
| 0093-3147 | Cephalexin | Cephalexin | 
| 0093-4175 | Cephalexin | Cephalexin | 
| 0093-4177 | Cephalexin | Cephalexin | 
| 0143-9769 | Cephalexin | Cephalexin | 
| 0143-9770 | Cephalexin | Cephalexin | 
| 0143-9897 | Cephalexin | Cephalexin | 
| 0143-9898 | Cephalexin | Cephalexin | 
| 67877-220 | Cephalexin | Cephalexin | 
| 67877-254 | Cephalexin | Cephalexin | 
| 67877-255 | Cephalexin | Cephalexin | 
| 67877-219 | Cephalexin | Cephalexin | 
| 68071-1585 | Cephalexin | Cephalexin | 
| 68071-4177 | Cephalexin | Cephalexin | 
| 68071-3186 | Cephalexin | Cephalexin | 
| 68071-4355 | Cephalexin | Cephalexin | 
| 68071-4342 | Cephalexin | Cephalexin | 
| 68071-4465 | Cephalexin | Cephalexin | 
| 68071-4233 | Cephalexin | Cephalexin | 
| 68071-4406 | Cephalexin | Cephalexin | 
| 68071-4429 | Cephalexin | Cephalexin | 
| 68071-4587 | Cephalexin | Cephalexin | 
| 68071-4516 | Cephalexin | Cephalexin | 
| 68071-4434 | Cephalexin | Cephalexin | 
| 0440-1243 | Cephalexin | Cephalexin | 
| 0440-7244 | Cephalexin | Cephalexin | 
| 68180-124 | cephalexin | cephalexin | 
| 68180-441 | cephalexin | cephalexin | 
| 68180-121 | Cephalexin | Cephalexin | 
| 68180-123 | cephalexin | cephalexin | 
| 68180-440 | cephalexin | cephalexin | 
| 68180-122 | Cephalexin | Cephalexin | 
| 68788-8986 | Cephalexin | Cephalexin | 
| 68788-9404 | Cephalexin | Cephalexin | 
| 68788-7271 | Cephalexin | Cephalexin | 
| 68788-9713 | Cephalexin | Cephalexin | 
| 68788-9326 | Cephalexin | Cephalexin | 
| 68788-9951 | cephalexin | cephalexin | 
| 68788-8994 | Cephalexin | Cephalexin | 
| 68788-7391 | Cephalexin | Cephalexin | 
| 68788-9539 | Cephalexin | Cephalexin | 
| 68788-9950 | cephalexin | cephalexin | 
| 68788-9956 | cephalexin | cephalexin | 
| 68788-9538 | Cephalexin | Cephalexin | 
| 68788-9752 | cephalexin | cephalexin | 
| 68788-9957 | cephalexin | cephalexin | 
| 69543-102 | Cephalexin | Cephalexin | 
| 69778-930 | Cephalexin | Cephalexin |